Bart J. F. van den Bemt

发表的论文13 篇，按出版时间

1. 1
   The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of conceptExpert Opinion on Drug Safety20243
2. 2
   Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort studyExpert Opinion on Drug Safety20240
3. 3
   Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s PerspectiveDrug Safety20234
4. 4
   Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesExpert Opinion on Drug Safety20236
5. 5
   Patients’ and health-care professionals’ perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative studyExpert Opinion on Drug Safety20227
6. 6
   Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort studyExpert Opinion on Drug Safety20221
7. 7
   Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionalsExpert Opinion on Drug Safety202216
8. 8
   Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomesExpert Opinion on Drug Safety20214
9. 9
   Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseasesExpert Opinion on Drug Safety20203
10. 10
    Immune-mediated inflammatory disease patients’ preferences in adverse drug reaction information regarding biologicsExpert Opinion on Drug Safety20209